About this trial

This long-term outcomes study is designed to collect safety and efficacy data on designated, commercially available, hip arthroplasty products.

Eligibility criteria

Qualifiers

Man or woman >18 years

Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study

Subjects who agreed for study participation.

Disqualifiers

Subjects with existing tumour and/or particularly high surgical risk-

Subjects with anaesthetic risk class IV or higher

Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.)

Contraindications for arthroplasty with a Corin hip devices as per product IFU

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

2,500 Participants
are grouped into 1 trial group

Locations

13
CHU de Bordeaux - Groupe Hospitalier Pellegrin33000, Bordeaux France
clinique Oxford Cannes06400, Cannes France
CH Dunkerque59385, Dunkirk France
Polyclinique Henin Beaumont62254, Hénin-Beaumont France

Sponsors and collaborators

Corin

Lead sponsor